XML 44 R28.htm IDEA: XBRL DOCUMENT
v3.22.4

Capital Stock and Share-Based Compensation Plans | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
Capital Stock and Share-Based Compensation Plans | Capital Stock and Share-Based Compensation Plans Capital Stock — We have two classes of common shares, Common Voting shares and Class A Common shares. The Class A Common shares are only entitled to vote on the election of the greater of three or one-third of the directors and other matters as required by Ohio law. In connection with the January 7, 2021 closing of the ION acquisition, we entered into a Securities Purchase Agreement with Berkshire Hathaway Inc., (“Berkshire Hathaway”), pursuant to which Berkshire Hathaway provided $600 million of financing in exchange for 6,000 Series A Preferred Shares of the Company. The Preferred Shares, having a face value of $100,000 per share, are perpetual and will be redeemable at the option of the Company beginning on the fifth anniversary of issuance, and redeemable at the option of the holders in the event of a Change of Control (as defined in the terms of the Preferred Shares), in each case at a redemption price of 105% of the face value, plus accrued and unpaid dividends (whether or not declared). As long as the Company pays quarterly dividends in cash on the Preferred Shares, the dividend rate will be 8% per annum. If dividends on the Preferred Shares, which compound quarterly, are not paid in full in cash, the rate will increase to 9% per annum for the remaining period of time that the Preferred Shares are outstanding. Preferred stock dividends were $48.0 million and $45.1 million in 2022 and 2021, respectively. Class A Common Shares Stock Warrant — In connection with the Preferred Shares issuance, Berkshire Hathaway also received a warrant to purchase up to 23.1 million Class A shares, at an exercise price of $13 per share. The warrant is exercisable at the holder’s option at any time or from time to time, in whole or in part, until the first anniversary of the date on which no Preferred Shares remain outstanding. Since the holder had the option to settle the warrant through cash payment of the exercise price and/or through surrendering portions of their Preferred Shares for the stated par value, a liability was recognized for the fair value of the warrant. The valuation model, classified within Level 3 of the fair value hierarchy, included inputs for the estimated term of the warrant, the historical volatility rate of Scripps common stock and the exercise price for the warrant. At time of issuance, the fair value of the warrant totaled $181 million and was being remeasured each reporting period with the changes in fair value of the warrant captured in the gains/losses on stock warrant caption in the Consolidated Statements of Operations. On May 14, 2021, the warrant agreement was amended to only permit settlement of the warrant through cash payment of the exercise price. Following the warrant amendment, the warrant is no longer accounted for as a liability award where mark-to-market changes in the fair value of the warrant are captured as gains or losses in our operating results. The fair value of the warrant was remeasured on May 14, 2021 at $280 million. The increase in our stock price during 2021 was the primary contributor to the increase in the fair value of the warrant. The value of the liability on the amendment date was reclassified to equity within the caption Additional Paid-in Capital. Share Repurchase Plan — Shares may be repurchased from time to time at management's discretion. Shares can be repurchased under the authorization via open market purchases or privately negotiated transactions, including accelerated stock repurchase transactions, block trades, or pursuant to trades intending to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. In November 2016, our Board of Directors authorized a share repurchase program of up to $100 million of our Class A Common shares. We repurchased a total of $50.3 million of shares under this authorization prior to its expiration on March 1, 2020. In February 2020, our Board of Directors authorized a new share repurchase program of up to $100 million of our Class A Common shares through March 1, 2022. No shares were repurchased under either authorization during 2022, 2021 or 2020. Under the terms of the Preferred Shares, we are prohibited from paying dividends on and repurchasing our common shares until all Preferred Shares are redeemed. Incentive Plans — The Company has a long-term incentive plan (the “Plan”) that permits the granting of incentive and nonqualified stock options, stock appreciation rights, restricted stock units ("RSUs"), restricted and unrestricted Class A Common shares and performance units to key employees and non-employee directors. We satisfy stock option exercises and vested stock awards with newly issued shares. We have not issued any new stock options since 2008. As of December 31, 2022, approximately 4.6 million shares were available for future stock compensation awards. Restricted Stock Units — Awards of RSUs generally require no payment by the employee. RSUs are converted into an equal number of Class A Common shares when vested. These awards generally vest over a three or four year period, conditioned upon the individual’s continued employment through that period. Awards vest immediately upon the retirement, death or disability of the employee or upon a change in control of Scripps or in the business in which the individual is employed. Unvested awards may be forfeited if employment is terminated for other reasons. Awards are nontransferable during the vesting period, but the awards are entitled to all the rights of an outstanding share, including receiving stock dividend equivalents. There are no post-vesting restrictions on awards granted to employees and non-employee directors. Long-term incentive compensation includes performance share awards. Performance share awards represent the right to receive an award of RSUs if certain performance measures are met. Each award specifies a target number of shares to be issued and the specific performance criteria that must be met. The number of shares that an employee receives may be less or more than the target number of shares depending on the extent to which the specified performance measures are met or exceeded. The following table summarizes our RSU activity:
|  |  |  | Fair Value
|  | Number of Shares |  | Weighted Average |  | Range of Prices
Unvested at December 31, 2019 |  | 1,358,438 |  |  | $ | 18.68 |  |  | $ 11-24
Awarded |  | 1,588,134 |  |  | 8.86 |  |  | 7-12
Vested |  | (739,633) |  |  | 11.52 |  |  | 7-17
Forfeited |  | (15,280) |  |  | 13.37 |  |  | 8-23
Unvested at December 31, 2020 |  | 2,191,659 |  |  | 12.22 |  |  | 7-23
Awarded |  | 1,375,565 |  |  | 22.63 |  |  | 14-23
Vested |  | (1,060,685) |  |  | 20.32 |  |  | 15-24
Forfeited |  | (121,043) |  |  | 16.19 |  |  | 9-23
Unvested at December 31, 2021 |  | 2,385,496 |  |  | 17.25 |  |  | 9-23
Awarded |  | 1,867,083 |  |  | 19.19 |  |  | 14-22
Vested |  | (1,147,220) |  |  | 21.20 |  |  | 11-22
Forfeited |  | (57,074) |  |  | 20.07 |  |  | 9-23
Unvested at December 31, 2022 |  | 3,048,285 |  |  | 18.57 |  |  | 9-23
The following table summarizes additional information about RSU vesting:
|  | For the years ended December 31,
(in thousands) |  | 2022 |  | 2021 |  | 2020
Fair value of RSUs vested |  | $ | 24,321 |  |  | $ | 21,548 |  |  | $ | 8,518 |
Tax benefits realized on vesting |  | 5,902 |  |  | 5,101 |  |  | 2,019 |
Share-based Compensation Costs Share-based compensation costs were as follows:
|  | For the years ended December 31,
(in thousands) |  | 2022 |  | 2021 |  | 2020
Total share-based compensation |  | $ | 21,596 |  |  | $ | 22,334 |  |  | $ | 14,507 |
Included in discontinued operations |  | — |  |  | — |  |  | (492) |
Included in continuing operations |  | $ | 21,596 |  |  | $ | 22,334 |  |  | $ | 14,015 |
Share-based compensation, net of tax |  | $ | 16,355 |  |  | $ | 17,047 |  |  | $ | 10,694 |
As of December 31, 2022, $33.1 million of total unrecognized compensation costs related to RSUs and performance shares is expected to be recognized over a weighted-average period of 2.3 years.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration